Although diverse mechanisms have been proposed to explain the increase of inflammatory cytokines in patients with type 2 diabetes, to our knowledge, this is the first study to describe an association between CD33 and the inflammatory cytokine profile in type 2 diabetes patients. This evidence concerns the gene CD33 and type 2 diabetes mellitus.